Vivus, Inc.:企業の戦略・SWOT・財務分析

◆英語タイトル:Vivus, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4706
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Vivus, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Vivus, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vivus, Inc. (Vivus or ‘the company’) is a biopharmaceutical company focused on research, development and commercialization of innovative and next-generation therapies which in turn addresses various medical needs of its patients. These products finds application in sleep apnea, obesity, sexual health and diabetes. The company’s Tacrolimus is in active clinical development phase which is used to treat patients suffering withpulmonary arterial hypertension (PAH). It manufactures and packs these products on contract basis. The company is headquartered in Campbell, California, the US.

Scope

- Detailed information on Vivus, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vivus, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Vivus, Inc. including a breakdown and examination of key business segments
- Intelligence on Vivus, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vivus, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vivus, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vivus, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vivus, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Vivus, Inc.: Company Overview
Vivus, Inc.: Overview and Key Facts
Vivus, Inc.: Overview
Vivus, Inc.: Key Facts
Vivus, Inc.: Key Employees
Vivus, Inc.: Key Employee Biographies
Vivus, Inc.: Major Products and Services
Vivus, Inc.: Company History
Vivus, Inc.: Management Statement
Vivus, Inc.: Locations and Subsidiaries
Vivus, Inc.: Key Competitors
Vivus, Inc.: Company Analysis
Vivus, Inc.: Business Description
Vivus, Inc.: SWOT Analysis
Vivus, Inc.: SWOT Overview
Vivus, Inc.: Strengths
Vivus, Inc.: Weaknesses
Vivus, Inc.: Opportunities
Vivus, Inc.: Threats
Vivus, Inc.: Corporate Financial Deals Activity
Vivus, Inc.: Financial Deals Overview
Vivus, Inc.: Targets and Partners
Vivus, Inc.: Top Deals 2016 – 2020YTD*
Vivus, Inc.: Mergers and Acquisitions
Vivus, Inc.: Capital Raising
Vivus, Inc.: Partnership
Vivus, Inc.: Recent Developments
Vivus, Inc.: News and Events Summary
Vivus, Inc.: Corporate Governance
Vivus, Inc.: Corporate Social Responsibility
Vivus, Inc.: Financial Deals
Vivus, Inc.: Financial Performance
Vivus, Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Vivus, Inc.: Key Facts
Table 2: Vivus, Inc.: Key Employees
Table 3: Vivus, Inc.: Company History
Table 4: Vivus, Inc.: Locations and Subsidiaries
Table 5: Vivus, Inc.: Key Competitors
Table 6: Vivus, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Vivus, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Vivus, Inc.: Targets and Partners
Table 9: Vivus, Inc.: Top Deals 2016 - 2020YTD*
Table 10: Vivus, Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 11: Vivus, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 12: Vivus, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 13: Vivus, Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 14: Vivus, Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 15: Vivus, Inc.: News and Events Summary
Table 16: Vivus, Inc.: Corporate Governance
Table 17: Vivus, Inc.: Corporate Social Responsibility
Table 18: Vivus, Inc.: Financial Deals
Table 19: Vivus, Inc.: Financial Performance
Table 20: Vivus, Inc.: Research & Development

★海外企業調査レポート[Vivus, Inc.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Suzlon Energy Ltd (SUZLON):企業の財務・戦略的SWOT分析
    Suzlon Energy Ltd (SUZLON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Cymbet Corp:電力:M&Aディール及び事業提携情報
    Summary Cymbet Corp (Cymbet) is a clean technology company that offers energy storage solutions for microelectronic systems. The company’s products include EnerChip, EnerChip solid state batteries, EnerChip bare die, EnerChip RTC and evaluation kits. Its devices offers new concept in energy storage …
  • Sanofi SA:戦略・SWOT・企業財務分析
    Sanofi SA - Strategy, SWOT and Corporate Finance Report Summary Sanofi SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Welch Allyn Inc:企業の戦略的SWOT分析
    Welch Allyn Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Ziehm Imaging GmbH-医療機器分野:企業M&A・提携分析
    Summary Ziehm Imaging GmbH (Ziehm Imaging) is a medical device company that specializes in the development, production and global marketing of mobile X-ray based imaging solutions. The company's product portfolio includes ziehm vision RFD 3D, ziehm vision RFD hybrid edition, ziehm vision RFD, ziehm …
  • Rohol-Aufsuchungs Aktiengesellschaft:石油・ガス:M&Aディール及び事業提携情報
    Summary Rohol-Aufsuchungs Aktiengesellschaft (RAG) is an oil and gas company. The company operates in oil and gas exploration, production and trading; and gas storage. It produces crude oil and natural gas. RAG offers services such as renewable energy projects development and crude oil stockpiling a …
  • Johnson & Johnson:企業の戦略・SWOT・財務情報
    Johnson & Johnson - Strategy, SWOT and Corporate Finance Report Summary Johnson & Johnson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Zanders GmbH:企業の戦略的SWOT分析
    Zanders GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Grupo Nutresa SA (NUTRESA):企業の財務・戦略的SWOT分析
    Grupo Nutresa SA (NUTRESA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Pudumjee Paper Products Limited:戦略・SWOT・企業財務分析
    Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report Summary Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Nuo Therapeutics Inc (AURX):医療機器:M&Aディール及び事業提携情報
    Summary Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. T …
  • Paysafe Group Plc:企業の戦略的SWOT分析
    Paysafe Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • CNP Assurances SA:企業のM&A・事業提携・投資動向
    CNP Assurances SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CNP Assurances SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • CenterPoint Energy Inc (CNP):電力:M&Aディール及び事業提携情報
    Summary CenterPoint Energy Inc (CenterPoint) is an energy utility company that carries out electric transmission and distribution, and natural gas distribution. It is also involved in natural gas sales and service, pipeline services and other field services. The company sells regulated intrastate na …
  • Histocell SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Histocell SL (Histocell), a subsidiary of Noray Biosciences Group, is a biopharmaceutical company that develops cell therapy and tissue engineering products for regenerative medicine. The company provides Wharton Gel Complex, medical devices, contract manufacturing and cell therapy programs, …
  • MSCI Inc. (MSCI):企業の財務・戦略的SWOT分析
    MSCI Inc. (MSCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • GKN plc:企業の戦略・SWOT・財務情報
    GKN plc - Strategy, SWOT and Corporate Finance Report Summary GKN plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • British Broadcasting Corporation:企業の戦略・SWOT・財務情報
    British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report Summary British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Vienna Insurance Group AG:企業の戦略・SWOT・財務情報
    Vienna Insurance Group AG - Strategy, SWOT and Corporate Finance Report Summary Vienna Insurance Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ypsomed Holding AG (YPSN)
    Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company

◆H&Iグローバルリサーチ株式会社のお客様(例)◆